mirage

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants

Repositorio ABACUS/Manakin

Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)